83 related articles for article (PubMed ID: 18186229)
1. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers].
Kimura T; Iio K; Obi Y; Hayashi T
Nihon Jinzo Gakkai Shi; 2007; 49(8):1007-13. PubMed ID: 18186229
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular hypertrophy in nondiabetic predialysis CKD.
Paoletti E; Bellino D; Cassottana P; Rolla D; Cannella G
Am J Kidney Dis; 2005 Aug; 46(2):320-7. PubMed ID: 16112052
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular hypertrophy in patients with chronic kidney disease under conservative treatment.
Bregman R; Lemos C; Pecoits Filho R; Abensur H; Draibe S; Bastos MG; Canziani ME
J Bras Nefrol; 2010 Mar; 32(1):83-8. PubMed ID: 21448524
[TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
Chijioke A; Makusidi AM; Kolo PM
Ann Afr Med; 2012; 11(1):21-6. PubMed ID: 22199043
[TBL] [Abstract][Full Text] [Related]
7. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
Datta S; Abraham G; Mathew M; Somasundaram H; Muralidharan TR; Moorthy A; Sathyasekaran ; Leslie N
J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
[TBL] [Abstract][Full Text] [Related]
9. [Left ventricular hypertrophy in the Spanish hypertensive population. The ERIC-HTA study].
Lozano JV; Redón J; Cea-Calvo L; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J
Rev Esp Cardiol; 2006 Feb; 59(2):136-42. PubMed ID: 16540035
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
11. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
12. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
13. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
Rudenko TE; Kutyrina IM; Shvetsov MIu
Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
[TBL] [Abstract][Full Text] [Related]
14. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
Smilde TD; Asselbergs FW; Hillege HL; Voors AA; Kors JA; Gansevoort RT; van Gilst WH; de Jong PE; Van Veldhuisen DJ
Am J Hypertens; 2005 Mar; 18(3):342-7. PubMed ID: 15797651
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses.
Mimura I; Nishi H; Mise N; Mori M; Sugimoto T
Nephrology (Carlton); 2010 Aug; 15(5):549-54. PubMed ID: 20649875
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States.
Stack AG; Saran R
Am J Kidney Dis; 2002 Dec; 40(6):1202-10. PubMed ID: 12460039
[TBL] [Abstract][Full Text] [Related]
18. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease.
Weiner DE; Tighiouart H; Vlagopoulos PT; Griffith JL; Salem DN; Levey AS; Sarnak MJ
J Am Soc Nephrol; 2005 Jun; 16(6):1803-10. PubMed ID: 15857925
[TBL] [Abstract][Full Text] [Related]
19. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey].
Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):458-63. PubMed ID: 15854551
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
Mark PB; Stewart GA; Gansevoort RT; Petrie CJ; McDonagh TA; Dargie HJ; Rodger RS; Jardine AG
Nephrol Dial Transplant; 2006 Feb; 21(2):402-10. PubMed ID: 16221702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
